Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs

Abstract Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vincent Montoya, Anita Y. M. Howe, Weiyan Y. Dong, Winnie Dong, Chanson J. Brumme, Andrea D. Olmstead, Kanna Hayashi, P. Richard Harrigan, Jeffrey B. Joy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9897a6ee8ee742759ddb6f3d56a742fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9897a6ee8ee742759ddb6f3d56a742fb
record_format dspace
spelling oai:doaj.org-article:9897a6ee8ee742759ddb6f3d56a742fb2021-12-02T17:01:57ZIntra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs10.1038/s41598-021-88132-82045-2322https://doaj.org/article/9897a6ee8ee742759ddb6f3d56a742fb2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88132-8https://doaj.org/toc/2045-2322Abstract Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide treatment. While intra-host viral diversity quantifications such as Shannon entropy have previously been utilized for estimating duration of infection, these studies characterize the viral population from only a relatively short segment of the HCV genome. In this study intra-host diversities were examined across the HCV genome in order to identify the region most reflective of time and the degree to which these estimates are influenced by high-risk activities including those associated with HCV acquisition. Shannon diversities were calculated for all regions of HCV from 78 longitudinally sampled individuals with known seroconversion timeframes. While the region of the HCV genome most accurately reflecting time resided within the NS3 gene, the gene region with the highest capacity to differentiate acute from chronic infections was identified within the NS5b region. Multivariate models predicting duration of infection from viral diversity significantly improved upon incorporation of variables associated with recent public, unsupervised drug use. These results could assist the development of strategic population treatment guidelines for high-risk individuals infected with HCV and offer insights into variables associated with a likelihood of transmission.Vincent MontoyaAnita Y. M. HoweWeiyan Y. DongWinnie DongChanson J. BrummeAndrea D. OlmsteadKanna HayashiP. Richard HarriganJeffrey B. JoyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Vincent Montoya
Anita Y. M. Howe
Weiyan Y. Dong
Winnie Dong
Chanson J. Brumme
Andrea D. Olmstead
Kanna Hayashi
P. Richard Harrigan
Jeffrey B. Joy
Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
description Abstract Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide treatment. While intra-host viral diversity quantifications such as Shannon entropy have previously been utilized for estimating duration of infection, these studies characterize the viral population from only a relatively short segment of the HCV genome. In this study intra-host diversities were examined across the HCV genome in order to identify the region most reflective of time and the degree to which these estimates are influenced by high-risk activities including those associated with HCV acquisition. Shannon diversities were calculated for all regions of HCV from 78 longitudinally sampled individuals with known seroconversion timeframes. While the region of the HCV genome most accurately reflecting time resided within the NS3 gene, the gene region with the highest capacity to differentiate acute from chronic infections was identified within the NS5b region. Multivariate models predicting duration of infection from viral diversity significantly improved upon incorporation of variables associated with recent public, unsupervised drug use. These results could assist the development of strategic population treatment guidelines for high-risk individuals infected with HCV and offer insights into variables associated with a likelihood of transmission.
format article
author Vincent Montoya
Anita Y. M. Howe
Weiyan Y. Dong
Winnie Dong
Chanson J. Brumme
Andrea D. Olmstead
Kanna Hayashi
P. Richard Harrigan
Jeffrey B. Joy
author_facet Vincent Montoya
Anita Y. M. Howe
Weiyan Y. Dong
Winnie Dong
Chanson J. Brumme
Andrea D. Olmstead
Kanna Hayashi
P. Richard Harrigan
Jeffrey B. Joy
author_sort Vincent Montoya
title Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
title_short Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
title_full Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
title_fullStr Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
title_full_unstemmed Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
title_sort intra-host evolutionary dynamics of the hepatitis c virus among people who inject drugs
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9897a6ee8ee742759ddb6f3d56a742fb
work_keys_str_mv AT vincentmontoya intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT anitaymhowe intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT weiyanydong intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT winniedong intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT chansonjbrumme intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT andreadolmstead intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT kannahayashi intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT prichardharrigan intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
AT jeffreybjoy intrahostevolutionarydynamicsofthehepatitiscvirusamongpeoplewhoinjectdrugs
_version_ 1718381984401588224